Search bioRxivSearch

bioRxiv · 10.1101/556183

Evaluation of the psychometric properties of the HIV Disability Questionnaire among adults living with HIV in the United Kingdom

Abstract

ObjectiveTo evaluate the psychometric properties of the HIV Disability Questionnaire (HDQ) among adults living with HIV in London, United Kingdom (UK). MethodsThis is a cross-sectional measurement study. We recruited and administered the self-reported HDQ, seven criterion measures, and a demographic questionnaire with adults living with HIV accessing HIV care. We determined median and interquartile ranges (IQR) for disability presence, severity and episodic scores (range 0-100). We calculated Cronbachs alpha () Kuder-Richardson-20 (KR-20) statistics for disability and episodic scores respectively (internal consistency reliability), smallest detectable change (SDC) for each HDQ severity item and domain (precision), and tested 36 a priori hypotheses assessing correlations between HDQ and criterion scores (construct validity). ResultsOf N=243 participants, all were male, median age 40 years, 94% currently taking antiretroviral therapy, and 22% living with [≥]2 concurrent health conditions. Median HDQ domain scores ranged from 0 (IQR: 0,7) (difficulties with day-to-day activities domain) to 27 (IQR: 14, 41) (uncertainty domain). Cronbachs alpha for the HDQ severity scale ranged from 0.85 (95% Confidence Interval (CI): 0.80-0.90) in the cognitive domain to 0.93 (95%CI: 0.91-0.94) in the mental-emotional domain. The KR-20 statistic for the HDQ episodic scale ranged from 0.74 (95%CI: 0.66-0.83) in the cognitive domain to 0.91 (95%CI: 0.89-0.94) in the uncertainty domain. SDC ranged from 7.3-15.0 points on the HDQ severity scale for difficulties with day-to-day activities and cognitive symptoms domains, respectively. The majority of the construct validity hypotheses (n=30/36, 83%) were confirmed. ConclusionsThe HDQ possesses internal consistency reliability and construct validity with varied precision when administered to males living with HIV in London, UK. Clinicians and researchers may use the HDQ to measure the nature and extent of disability experienced by PLHIV in the UK, and to inform HIV service provision to address the health-related challenges among PLHIV.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Brown, D. A., Simmons, B., Boffito, M., Aubry, R., Nwokolo, N., Harding, R., O'Brien, K. K.. 2019-02-20. Evaluation of the psychometric properties of the HIV Disability Questionnaire among adults living with HIV in the United Kingdom. https://doi.org/10.1101/556183

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Defining Hospital Catchment Areas Using Multiscale Community Detection: A Case Study for Planned Orthopaedic Care in England

BackgroundThe English National Health Service 5-year Forward View emphasises the importance of integration of hospital and community services. Understanding the population a hospital serves is critical to formulating strategies for community engagement and determining their accountability for populations. Existing methods to define catchment areas are unable to adapt to dilute health care markets in urban areas where populations may interact with several different hospitals. Formulating catchment areas which permit the inclusion of more than one hospital based upon patient behaviour allows for collaboration between hospitals to reach out into the communities they collectively share.\n\nMethodThe proportion of presentations from all census Middle Super Output Areas (MSOAs) to every hospital trust providing orthopaedic care in England were calculated. The cosine similarity of all MSOAs to one another was computed from these proportions. Multiscale community detection was applied to planned orthopaedic surgical admissions in England from 1st April 2011 to 31st March 2015. Stable community configurations were identified and the proportion of patients presenting to hospitals located within the catchment area in which they resided was calculated. The performance of these catchment areas was compared to conventional methods for assigning mutually exclusive catchment areas.\n\nResults2,602,066 planned orthopaedic surgical admissions were identified for patients resident in 6,791 MSOAs in England attending 140 different hospital trusts. Markov multiscale community detection revealed five stable catchment area configurations consisting of 127, 51, 26, 15 and 11 catchment areas. Between 78% (127 catchments) and 93% (11 catchments) of clinical presentations were to hospitals within a patients allocated catchment area compared to 76% for the \"first past the post\" method.\n\nConclusionsMultiscale community detection is a novel and effective, data-driven method for defining mutually exclusive, collectively exhaustive catchment areas in secondary care. In urban areas with dilute healthcare markets, the model favours collaboration between hospitals in covering a clearly delineated but shared catchment, and thereby produces simplified and more representative catchment areas.

epidemiology

Genome-wide association study of plasma lipids

There is continuous interest in the genetic determinants of plasma triglycerides (TGs) and phospholipids and their role in the etiology of cardiovascular disease (CVD). Here, we report the results of a Dutch genome wide association study (GWAS) of an in-house developed lipidomics platform, focusing on 90 plasma lipids. Lipids were assessed by liquid chromatography mass spectrometry in participants from the Leiden Longevity Study, the Netherlands Twin Register and the Erasmus Rucphen Family (ERF) study and meta-analysed, resulting in a sample size of 5537 participants. In addition, we performed genetic correlation analyses between the 90 plasma lipids and markers of metabolic health, as well as vascular pathology and CVD combining our GWAS results with publicly available GWAS outputs. We replicated previously known associations between 34 lipids and 10 lipid quantitative trait loci (lipQTL) (GCKR, APOA1, FADS1, SGPP1,TMEM229B, LIPC, PDXDC1, CETP, CERS4 and SPTLC3) with metabolome-wide (P < 1.61 x 10-9) significance. Moreover, we report 6 novel phospholipid-related and 5 triglyceride (TG)-related loci: SGGP1 (SM21:0), SPTLC3 (SM21:0 and SM25:1), FADS1 (LPCO16:1, PC38:2, PEO36:5, PEO38:5, TG56:5, TG56:6, and TG56:7), TMEM229 (LPCO16:1), GCKR (TG50:2), and APOA1 (TG54:4). In addition, we report suggestively significant (P < 5 x 10-8) associations mapping to eleven novel lipid quantitative trait loci (lipQTLs), three of which are supported by mining previous GWAS data: MAU (PC34:4), LDLR (SM16:0), and MLXIPL (TG48:1 and TG50:1)). Genetic correlation analysis indicates that one specific specific sphingomyelin, SM22:0, shares common genetic background with CVD. Levels of SM22:0 also positively associate with carotid artery intima-media thickness in the ERF study, and this observation is independent of LDL-C level. Our findings yield higher resolution of plasma lipid species and new insights in the biology of circulating phosholipids and their relation to CVD risk.

epidemiology

Optimizing systemic insecticide use to improve malaria control

Long lasting insecticidal nets and indoor residual sprays have significantly reduced the burden of malaria. However, several hurdles remain before elimination can be achieved: mosquito vectors have developed resistance to public health insecticides, including pyrethroids, and have altered their biting behaviour to avoid these indoor control tools. Systemic insecticides, drugs applied directly to blood-hosts to kill mosquitoes that take a blood meal, offer a promising vector control option. To date, most studies focus on repurposing ivermectin, a drug used extensively to treat river blindness. There is concern that over-dependence on a single drug will inevitably repeat past experiences with the rapid spread of pyrethroid resistance in malaria vectors. Diversifying the arsenal of systemic insecticides used for mass drug administration would improve this strategys sustainability. Here, a review was conducted to identify systemic insecticide candidates and consolidate their pharmacokinetic/pharmacodynamic properties. The impact of alternative integrated vector control options and different dosing regimens on malaria transmission reduction are illustrated through a mathematical model simulation. The review identified drugs from four classes commonly used in livestock and companion animals: avermectics, milbemycins, isoxazolines, and spinosyns. Simulations predicted that isoxazoline and spinosyn drugs were promising candidates for mass drug administration, as they were predicted to need less frequent application than avermectins and milbemycins to maintain mosquitocidal blood concentrations. These findings will provide a guide for investigating and applying different systemic insecticides to achieve better mosquito control strategies.\n\nSignificanceThe widespread use of long lasting insecticidal nets (LLINs) and indoor residual spray has selected for mosquitoes that are resistant to pyrethroids or avoid exposure by feeding outdoors or on livestock. Systemic insecticides, drugs that render a hosts blood toxic to feeding mosquitoes, could be an effective control strategy for mosquitoes with pyrethroid resistance and/or outdoor feeding tendencies. Here, a number of existing systemic insecticide candidates are identified and their pharmacokinetic properties in different drug-host-route scenarios consolidated. These data were used to parameterise a mathematical model that illustrated the projected gains achievable in malaria control programmes already employing LLINs. The findings provide a guide for investigating and applying different systemic insecticides to improve mosquito control strategies and reduce malaria transmission.

epidemiology